AIM
Axiom Investment Management’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Hold |
0
| – | – | – | 274 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 445 |
|
2022
Q1 | – | Sell |
-1,548
| Closed | -$428K | – | 129 |
|
2021
Q4 | $428K | Hold |
1,548
| – | – | 0.41% | 64 |
|
2021
Q3 | $357K | Sell |
1,548
-1,090
| -41% | -$251K | 0.36% | 67 |
|
2021
Q2 | $605K | Buy |
2,638
+76
| +3% | +$17.4K | 0.47% | 56 |
|
2021
Q1 | $479K | Buy |
2,562
+27
| +1% | +$5.05K | 0.39% | 70 |
|
2020
Q4 | $436 | Buy |
2,535
+960
| +61% | +$165 | 0.4% | 59 |
|
2020
Q3 | $234K | Sell |
1,575
-92
| -6% | -$13.7K | 0.26% | 95 |
|
2020
Q2 | $274K | Hold |
1,667
| – | – | 0.36% | 77 |
|
2020
Q1 | $231K | Sell |
1,667
-93
| -5% | -$12.9K | 0.41% | 72 |
|
2019
Q4 | $232K | Sell |
1,760
-9,642
| -85% | -$1.27M | 0.33% | 91 |
|
2019
Q3 | $1.28M | Sell |
11,402
-30,153
| -73% | -$3.37M | 0.97% | 27 |
|
2019
Q2 | $4.6M | Buy |
41,555
+262
| +0.6% | +$29K | 0.83% | 26 |
|
2019
Q1 | $5.36M | Sell |
41,293
-884
| -2% | -$115K | 1.02% | 20 |
|
2018
Q4 | $4.88M | Buy |
+42,177
| New | +$4.88M | 1.03% | 20 |
|